Vigilant Capital Management’s Moderna MRNA Stock Holding History

Vigilant Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$91K	Hold	750	–	–	0.01%	223
2023 Q1	$115K	Hold	750	–	–	0.01%	191
2022 Q4	$135K	Hold	750	–	–	0.01%	177
2022 Q3	$89K	Hold	750	–	–	0.01%	231
2022 Q2	$107K	Hold	750	–	–	0.01%	209
2022 Q1	$129K	Sell	750 -8	-1%	-$1.35K	0.01%	212
2021 Q4	$193K	Hold	758	–	–	0.01%	201
2021 Q3	$292K	Hold	758	–	–	0.02%	124
2021 Q2	$178K	Buy	758 +8	+1%	+$1.43K	0.01%	164
2021 Q1	$98K	Hold	750	–	–	0.01%	196
2020 Q4	$78K	Hold	750	–	–	0.01%	191
2020 Q3	$53K	Hold	750	–	–	0.01%	217
2020 Q2	$48K	Buy	+750	New	+$41.1K	0.01%	209

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vigilant Capital Management's MRNA Position: Q2 2023 in Review

Vigilant Capital Management held its Moderna (MRNA) position steady in Q2 2023 at 750 shares worth $91K. The position accounts for 0.01% of the portfolio, ranked #223.

Vigilant Capital Management first reported a position in MRNA in Q2 2020 and has held it in 13 quarters since. The position peaked at $292K in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

Vigilant Capital Management held 750 shares of Moderna worth $91K as of Q2 2023.
Vigilant Capital Management left its Moderna share count unchanged in Q2 2023.
Moderna made up 0.01% of Vigilant Capital Management's portfolio in Q2 2023, its #223 holding.
Vigilant Capital Management first reported a position in Moderna in Q2 2020 and has held it in 13 quarters since.
Vigilant Capital Management's Moderna position peaked at $292K in Q3 2021.
965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Vigilant Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.